Mogrol-mediated enhancement of radiotherapy sensitivity in non-small cell lung cancer: a mechanistic study

Author:

Yin Zhongbo1,Zhang Xuedong1,Sun Xiao2,Huo Yunlong3,Ji Nan4,Chen Keyan5ORCID

Affiliation:

1. Department of Pathology, Baoan Central Hospital of Shenzhen, Shenzhen, Guangdong, China

2. Master Degree Candidate, Affiliated Central Hospital of Shenyang Medical College, Shenyang, Liaoning, China

3. Department of Pathology, Shengjing Hospital affiliated to China Medical University, Shenyang, Liaoning, China

4. Department of Docimasiology, Baoan Central Hospital of Shenzhen, China, Shenzhen, Guangdong, China

5. Department of Laboratory Animal Science, China Medical University, Shenyang, Liaoning, China

Abstract

Mogrol enhances non-small cell lung cancer (NSCLC) cell sensitivity to radiotherapy by downregulating USP22 through the ERK/CREB pathway, reducing COX2 expression. These findings highlight mogrol’s potential as an adjunct to improve NSCLC radiotherapy and open avenues for further research and clinical applications.

Funder

MOST | National Natural Science Foundation of China

Publisher

American Physiological Society

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3